MedGenome is driven to enable clinicians to deliver the best outcomes to their patients. Our passion to deliver actionable insights to clinicians has resulted in the development of “Claria” - a suite of NGS (Next-Generation Sequencing) technology-based solutions for reproductive testing. Claria offers the most accurate Non-Invasive Prenatal Screening Test (NIPT), the Genetic Carrier Screening Test and the Preimplantation Genetic Screening/Diagnosis (PGS/PGD).
In addition to this Claria now offers not just advanced NGS based tests but also routine prenatal diagnostics and cytogenetic tests
Cytogenetic testing can be done on various body tissues in prenatal or postnatal situations. Various numerical or structural abnormalities that lead to phenotypic abnormalities can be detected using these techniques. At MedGenome- Centre for Genetic Healthcare we offer the following tests::
Karyotyping can be done on various body tissues in prenatal or postnatal life. Numerical or structural abnormalities can lead to various phenotypic abnormalities. Karyotyping is done on blood, bone marrow and products of conception.
FISH technique is used to detect numerical as well as minor structural re arrangements. Currently it is available for fetal aneuploidy, micro deletion syndromes and oncology.
CMAs are a high resolution molecular genetic test which screen for very small gains and losses (copy number variants, in kilobase ranges) as well as loss of heterozygosity in the DNA of an individual. CMAs are commonly used to test for genetic abnormalities for individuals with unexplained developmental delay/intellectual disability (DD/ID), autism spectrum disorder (ASD) or multiple congenital anomalies (MCA).